New: NCI-funded clinical trial search
Mednet Logo

How do you decide between antibiotic prophylaxis and supplemental immunoglobulin therapy in specific antibody deficiency?

Do you take a stepwise approach? Do you value certain clinical factors more than others? (eg, infection frequency, infection severity, degree of polysaccharide vaccination response, comorbidities, age, prior culture data, imaging, etc.)